Argan (AGX) is rated as a 'Strong Buy' due to significant macro trends in AI and data center demand, which have driven its backlog to $2.9 billion, more than double the previous year. Although revenue growth slowed to 12.7% year-over-year in Q4 2026, the large backlog is expected to convert into strong revenue growth over the next three years. Despite a high price-to-earnings ratio of 69, projected revenue growth of 32% and margin expansion above 20% justify a potential market cap increase of 34–88% from current levels. Key risks include macroeconomic changes affecting AI spending and possible delays in backlog conversion, but management's strong track record supports confidence in the outlook.
Funnel has introduced Digital Measurement, a new marketing mix modeling (MMM) software that integrates MMM, Multi-Touch Attribution (MTA), and ad platform signals into one calibrated system. This approach addresses the limitations of relying on a sin...
Zealand Pharma held an Extraordinary General Meeting on May 26, 2026, where all proposals were approved, including the election of Camilla Sylvest to the Board of Directors. The board now consists of seven shareholder-elected members and four employe...
Nvidia has been a top AI investment as demand for AI chips surged, but the next wave of IPOs from major AI customers like SpaceX, OpenAI, and Anthropic could shift investor focus. These companies, while not competitors in hardware, may compete for in...
Salazar Resources announced a new copper-gold porphyry system discovery at its 100%-owned Monja Project in southern Ecuador, featuring high-grade surface samples. This discovery comes as global copper prices hit record highs due to supply deficits, i...
Novee has introduced Agentic Fix, an enhancement to its AI penetration testing platform that automates the transition from identifying security vulnerabilities to deploying fixes. This tool generates detailed remediation guidance based on validated e...
